Maria A. Blasco, PhD in 1993 for her research on viral DNA polymerases at the Centro de Biología Molecular in Madrid (Spain) under the supervision of Prof. Margarita Salas. That same year, Blasco joined the Cold Spring Harbor Laboratory in New York (USA) as a Postdoctoral Fellow under the leadership of Prof. Carol W. Greider. In 1997 she returned to Spain to start her own research Group at the Centro Nacional de Biotecnología in Madrid. She joined the Spanish National Cancer Research Centre (CNIO) in Madrid in 2003 as Head of the Telomeres and Telomerase group and Director of the Molecular Oncology Programme. She served as CNIO Vice-director from 2005 to 2011 and she is the current CNIO Director (since July 2011). To date (February 2016), Maria A. Blasco has contributed a total of 219 scientific papers, including those published in high-ranking journals (8 in Cell, 6 in Nature Genetics, 5 in Nature Cell Biology, 4 in Nature, 2 in Cell Stem Cell, 2 in Nature Reviews Cancer, 2 in Nature Genetics, 2 in Science), totalling over 21,000 citations. Her h-index is of 75. Maria A. Blasco also has three granted international patents, one of which was licensed to the company Life Length, SL (www.lifelength.com), a Madrid-based biotech company. Maria A Blasco received a Doctorate Honoris Causa from Universidad Carlos III (Madrid, Spain) in 2014. That same year Blasco was elected Fellow of the Royal Academy of Pharmacy of Spain."La Fundación Ramón Areces no se hace responsable de las opiniones, comentarios o manifestaciones realizados por las personas que participan en sus actividades."
